{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:38:10Z","timestamp":1789562290592,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102132","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:56:11Z","timestamp":1759301771000},"page":"102132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fenofibrate in managing cholestatic pruritus in paediatric patients"],"prefix":"10.1016","volume":"31","author":[{"given":"Jes\u00fas","family":"Quintero-Bernabeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-6374","authenticated-orcid":false,"given":"Javier","family":"Juamperez-Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Padr\u00f3s-Fornieles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Larrarte-King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis","family":"Vidal-Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Clemente-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4545-8560","authenticated-orcid":false,"given":"Aurora","family":"Fern\u00e1ndez-Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Andr\u00e9s","family":"Molino-Gahete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mercadal-Hally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.aohep.2025.102132_bib0001","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clinre.2017.08.007","article-title":"An update on the physiopathology and therapeutic management of cholestatic pruritus in children","volume":"42","author":"Th\u00e9baut","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"15","key":"10.1016\/j.aohep.2025.102132_bib0002","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","article-title":"Pathogenesis and treatment of pruritus in cholestasis","volume":"68","author":"Kremer","year":"2008","journal-title":"Drugs"},{"issue":"19","key":"10.1016\/j.aohep.2025.102132_bib0003","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3748\/wjg.v23.i19.3418","article-title":"Recent advances in the management of pruritus in chronic liver diseases","volume":"23","author":"Tajiri","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102132_bib0004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40271-017-0266-4","article-title":"Development of a novel tool to assess the impact of itching in pediatric cholestasis","volume":"11","author":"Kamath","year":"2018","journal-title":"The Patient"},{"issue":"3","key":"10.1016\/j.aohep.2025.102132_bib0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2016.04.032","article-title":"Biliary atresia and other cholestatic childhood diseases: advances and future challenges","volume":"65","author":"Verkade","year":"2016","journal-title":"J Hepatol. Sep"},{"issue":"3","key":"10.1016\/j.aohep.2025.102132_bib0006","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut. Mar"},{"issue":"4","key":"10.1016\/j.aohep.2025.102132_bib0007","first-page":"442","article-title":"Use of rifampin for severe pruritus in children with chronic cholestasis","volume":"29","author":"Yerushalmi","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr. Oct"},{"issue":"4","key":"10.1016\/j.aohep.2025.102132_bib0008","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0016-5085(90)90027-X","article-title":"Rifampin relieves pruritus in children with cholestatic liver disease","volume":"98","author":"Cynamon","year":"1990","journal-title":"Gastroenterology. Apr"},{"issue":"4","key":"10.1016\/j.aohep.2025.102132_bib0009","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23821","article-title":"The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Kuiper","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.102132_bib0010","article-title":"Natural history of liver disease in a large international cohort of children with Alagille syndrome: results from the GALA study","author":"Vandriel","year":"2022","journal-title":"Hepatolology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102132_bib0011","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"van Wessel","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102132_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101751","article-title":"Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: phase 2 study","volume":"45","author":"Baumann","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"7","key":"10.1016\/j.aohep.2025.102132_bib0013","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S2468-1253(24)00074-8","article-title":"Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"9","author":"Ovchinsky","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2025.102132_bib0014","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol. Sep"},{"issue":"7","key":"10.1016\/j.aohep.2025.102132_bib0015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2468-1253(24)00080-3","article-title":"Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Miethke","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10311","key":"10.1016\/j.aohep.2025.102132_bib0016","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.aohep.2025.102132_bib0017","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/HEP.0000000000000727","article-title":"Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA","volume":"79","author":"Hansen","year":"2024","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2025.102132_bib0018","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.26018","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","volume":"57","author":"Honda","year":"2013","journal-title":"Hepatology. May"},{"issue":"3","key":"10.1016\/j.aohep.2025.102132_bib0019","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.aohep.2025.102132_bib0020","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med. Jun"},{"issue":"7","key":"10.1016\/j.aohep.2025.102132_bib0021","first-page":"1192","article-title":"Indirect neonatal hyperbilirubinemia and the role of fenofibrate as an adjuvant to phototherapy","volume":"10","author":"Shabo","year":"2023","journal-title":"Children (Basel)"},{"issue":"10","key":"10.1016\/j.aohep.2025.102132_bib0022","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4158\/CS-2020-0490","article-title":"Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm - 2020 executive summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.aohep.2025.102132_bib0023","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1017\/cts.2023.35","article-title":"Oral fenofibrate for hyperbilirubinemia in term neonates: A single-blind randomized controlled trial","volume":"7","author":"Saadat","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.aohep.2025.102132_bib0024","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.metabol.2008.08.005","article-title":"Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis","volume":"58","author":"Nagasaka","year":"2009","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.aohep.2025.102132_bib0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2009.09586.x","article-title":"The 5-D itch scale: a new measure of pruritus","volume":"162","author":"Elman","year":"2010","journal-title":"Br J Dermatol"},{"issue":"Pt 3","key":"10.1016\/j.aohep.2025.102132_bib0026","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj20020981","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice","volume":"369","author":"Kok","year":"2003","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.aohep.2025.102132_bib0027","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.aohep.2025.102132_bib0028","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/cells13151296","article-title":"PPAR-mediated bile acid glucuronidation: therapeutic targets for the treatment of cholestatic liver diseases","volume":"13","author":"Gallucci","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.aohep.2025.102132_bib0029","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.105.093765","article-title":"Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha","volume":"317","author":"Moffit","year":"2006","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:53:30Z","timestamp":1780649610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003576"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102132","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate in managing cholestatic pruritus in paediatric patients","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102132"}}